Report Detail
Global Melanocortin Receptor 4 Market Insights, Forecast to 2025
- RnM2850216 |
- 13 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The global Melanocortin Receptor 4 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Melanocortin Receptor 4 market based on company, product type, end user and key regions.
This report studies the global market size of Melanocortin Receptor 4 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Melanocortin Receptor 4 in these regions.
This research report categorizes the global Melanocortin Receptor 4 market by top players/brands, region, type and end user. This report also studies the global Melanocortin Receptor 4 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca Plc
Mallinckrodt Plc
Obexia AG
Palatin Technologies, Inc.
Pfizer Inc.
Retrophin Inc.
Rhythm Pharmaceuticals, Inc.
Market size by Product
Bremelanotide
Corticotropin
Cosyntropin
Others
Market size by End User
Metabolic Disorder
Women's Health
Genito Urinary System
Infection Disease
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Melanocortin Receptor 4 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Melanocortin Receptor 4 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Melanocortin Receptor 4 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Melanocortin Receptor 4 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Melanocortin Receptor 4 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Melanocortin Receptor 4 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Melanocortin Receptor 4 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Product
- 1.4.2 Bremelanotide
- 1.4.3 Corticotropin
- 1.4.4 Cosyntropin
- 1.4.5 Others
- 1.5 Market by End User
- 1.5.1 Global Melanocortin Receptor 4 Market Size Growth Rate by End User
- 1.5.2 Metabolic Disorder
- 1.5.3 Women's Health
- 1.5.4 Genito Urinary System
- 1.5.5 Infection Disease
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Melanocortin Receptor 4 Market Size
- 2.1.1 Global Melanocortin Receptor 4 Revenue 2014-2025
- 2.1.2 Global Melanocortin Receptor 4 Sales 2014-2025
- 2.2 Melanocortin Receptor 4 Growth Rate by Regions
- 2.2.1 Global Melanocortin Receptor 4 Sales by Regions
- 2.2.2 Global Melanocortin Receptor 4 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Melanocortin Receptor 4 Sales by Manufacturers
- 3.1.1 Melanocortin Receptor 4 Sales by Manufacturers
- 3.1.2 Melanocortin Receptor 4 Sales Market Share by Manufacturers
- 3.1.3 Global Melanocortin Receptor 4 Market Concentration Ratio (CR5 and HHI)
- 3.2 Melanocortin Receptor 4 Revenue by Manufacturers
- 3.2.1 Melanocortin Receptor 4 Revenue by Manufacturers (2014-2019)
- 3.2.2 Melanocortin Receptor 4 Revenue Share by Manufacturers (2014-2019)
- 3.3 Melanocortin Receptor 4 Price by Manufacturers
- 3.4 Melanocortin Receptor 4 Manufacturing Base Distribution, Product Types
- 3.4.1 Melanocortin Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Melanocortin Receptor 4 Product Type
- 3.4.3 Date of International Manufacturers Enter into Melanocortin Receptor 4 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Melanocortin Receptor 4 Sales by Product
- 4.2 Global Melanocortin Receptor 4 Revenue by Product
- 4.3 Melanocortin Receptor 4 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Melanocortin Receptor 4 Breakdown Data by End User
6 North America
- 6.1 North America Melanocortin Receptor 4 by Countries
- 6.1.1 North America Melanocortin Receptor 4 Sales by Countries
- 6.1.2 North America Melanocortin Receptor 4 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Melanocortin Receptor 4 by Product
- 6.3 North America Melanocortin Receptor 4 by End User
7 Europe
- 7.1 Europe Melanocortin Receptor 4 by Countries
- 7.1.1 Europe Melanocortin Receptor 4 Sales by Countries
- 7.1.2 Europe Melanocortin Receptor 4 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Melanocortin Receptor 4 by Product
- 7.3 Europe Melanocortin Receptor 4 by End User
8 Asia Pacific
- 8.1 Asia Pacific Melanocortin Receptor 4 by Countries
- 8.1.1 Asia Pacific Melanocortin Receptor 4 Sales by Countries
- 8.1.2 Asia Pacific Melanocortin Receptor 4 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Melanocortin Receptor 4 by Product
- 8.3 Asia Pacific Melanocortin Receptor 4 by End User
9 Central & South America
- 9.1 Central & South America Melanocortin Receptor 4 by Countries
- 9.1.1 Central & South America Melanocortin Receptor 4 Sales by Countries
- 9.1.2 Central & South America Melanocortin Receptor 4 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Melanocortin Receptor 4 by Product
- 9.3 Central & South America Melanocortin Receptor 4 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Melanocortin Receptor 4 by Countries
- 10.1.1 Middle East and Africa Melanocortin Receptor 4 Sales by Countries
- 10.1.2 Middle East and Africa Melanocortin Receptor 4 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Melanocortin Receptor 4 by Product
- 10.3 Middle East and Africa Melanocortin Receptor 4 by End User
11 Company Profiles
- 11.1 AstraZeneca Plc
- 11.1.1 AstraZeneca Plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Plc Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Plc Melanocortin Receptor 4 Products Offered
- 11.1.5 AstraZeneca Plc Recent Development
- 11.2 Mallinckrodt Plc
- 11.2.1 Mallinckrodt Plc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Mallinckrodt Plc Melanocortin Receptor 4 Products Offered
- 11.2.5 Mallinckrodt Plc Recent Development
- 11.3 Obexia AG
- 11.3.1 Obexia AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Obexia AG Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Obexia AG Melanocortin Receptor 4 Products Offered
- 11.3.5 Obexia AG Recent Development
- 11.4 Palatin Technologies, Inc.
- 11.4.1 Palatin Technologies, Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Palatin Technologies, Inc. Melanocortin Receptor 4 Products Offered
- 11.4.5 Palatin Technologies, Inc. Recent Development
- 11.5 Pfizer Inc.
- 11.5.1 Pfizer Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Inc. Melanocortin Receptor 4 Products Offered
- 11.5.5 Pfizer Inc. Recent Development
- 11.6 Retrophin Inc.
- 11.6.1 Retrophin Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Retrophin Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Retrophin Inc. Melanocortin Receptor 4 Products Offered
- 11.6.5 Retrophin Inc. Recent Development
- 11.7 Rhythm Pharmaceuticals, Inc.
- 11.7.1 Rhythm Pharmaceuticals, Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Products Offered
- 11.7.5 Rhythm Pharmaceuticals, Inc. Recent Development
12 Future Forecast
- 12.1 Melanocortin Receptor 4 Market Forecast by Regions
- 12.1.1 Global Melanocortin Receptor 4 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Melanocortin Receptor 4 Revenue Forecast by Regions 2019-2025
- 12.2 Melanocortin Receptor 4 Market Forecast by Product
- 12.2.1 Global Melanocortin Receptor 4 Sales Forecast by Product 2019-2025
- 12.2.2 Global Melanocortin Receptor 4 Revenue Forecast by Product 2019-2025
- 12.3 Melanocortin Receptor 4 Market Forecast by End User
- 12.4 North America Melanocortin Receptor 4 Forecast
- 12.5 Europe Melanocortin Receptor 4 Forecast
- 12.6 Asia Pacific Melanocortin Receptor 4 Forecast
- 12.7 Central & South America Melanocortin Receptor 4 Forecast
- 12.8 Middle East and Africa Melanocortin Receptor 4 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Melanocortin Receptor 4 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Melanocortin Receptor 4 . Industry analysis & Market Report on Melanocortin Receptor 4 is a syndicated market report, published as Global Melanocortin Receptor 4 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Melanocortin Receptor 4 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
